EPZICOM (abacavir/lamivudine) Patient Assistance Program
Don’t let the high cost of brand HIV NRTI backbone therapy disrupt your treatment. We help eligible patients access Epzicom (abacavir/lamivudine) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Epzicom (abacavir 600 mg / lamivudine 300 mg) is FDA-approved as a once-daily fixed-dose combination NRTI backbone for HIV-1 antiretroviral therapy in adults and pediatric patients (≥25 kg). It must be combined with at least one other antiretroviral.
- Without assistance, brand Epzicom costs commonly run approximately $1,800–$2,200 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Epzicom for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic abacavir/lamivudine is now widely available in the U.S. at substantially lower cost — often $50–$150/month with a coupon. HLA-B*5701 testing is REQUIRED before starting due to severe abacavir hypersensitivity risk in HLA-B*5701-positive patients (5–8% prevalence). Many adults take this NRTI backbone as part of single-tablet Triumeq (DTG/ABC/3TC).
What Is Epzicom Prescription Assistance Program?
The Epzicom Prescription Assistance Program is a manufacturer-sponsored initiative that provides Epzicom at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for HIV patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, HLA-B*5701 testing documentation, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, brand Epzicom costs roughly $1,800–$2,200/month. Generic abacavir/lamivudine is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$2,150 | Save ~$2,080/mo |
| CVS Pharmacy (brand) | ~$2,200 | Save ~$2,130/mo |
| Walmart (brand) | ~$1,900 | Save ~$1,830/mo |
| Costco (brand) | ~$1,850 | Save ~$1,780/mo |
Generic abacavir/3TC | ~$100 | Already low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Epzicom Prescription Program?
The Patient Assistance Program is free to apply for and provides Epzicom at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic abacavir/lamivudine widely available at much lower cost, generic is usually the cheaper path for most patients.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Epzicom:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $1,800–$2,200 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Epzicom assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Epzicom Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Epzicom :
Epzicom (abacavir/lamivudine) is a once-daily fixed-dose combination NRTI backbone tablet used as part of combination antiretroviral therapy for HIV-1. It combines two NRTIs — abacavir (a guanosine analog) and lamivudine (a cytidine analog) — to provide a complete NRTI backbone in one tablet, which is then combined with a third antiretroviral (typically an INSTI like dolutegravir).
How Epzicom Injection Works:
The HIV-1 virus relies on a reverse transcriptase enzyme to convert its RNA genome into DNA so it can integrate into host chromosomes. Epzicom provides a robust backbone by combining abacavir (a guanosine analog) and lamivudine (a cytidine analog) to attack this enzyme from two different bases. Once inside cells, both drugs are phosphorylated and compete with natural components to incorporate into viral DNA, effectively terminating the growing chain because they lack a 3′-OH group. Unlike tenofovir-based alternatives, this combination avoids kidney and bone toxicity, though it does require specific genetic testing before use to prevent a severe hypersensitivity reaction.
Form and use:
Epzicom is prescribed as a single tablet taken by mouth once every day, and it can be administered with or without food. To function effectively, it cannot be used alone and must be combined with at least one other antiretroviral medication, which is typically an INSTI or an NNRTI. Crucially, patients must undergo HLA-B5701 testing before starting the medication to screen for risks. Under no circumstances should Epzicom ever be given to a patient who tests positive for the HLA-B5701 allele.
Generic availability:
The generic version of abacavir/lamivudine is widely available across the U.S. at a significantly lower cost compared to the brand-name Epzicom. Many adults currently take this specific drug combination as a component of the single-tablet regimen known as Triumeq. The other primary backbone options available to patients are tenofovir/emtricitabine, sold as generic Truvada or brand-name Descovy. Choosing between these available backbones depends entirely on a patient’s HLA-B*5701 status, kidney function, bone health, and hepatitis B status.
Warnings:
Epzicom features a boxed warning for severe, sometimes fatal abacavir hypersensitivity reactions in HLA-B*5701-positive individuals, and the drug must never be restarted if a reaction is suspected. It also carries a boxed warning for severe, acute HBV exacerbations if lamivudine is stopped in patients who are co-infected with hepatitis B. Additional warnings include risks of lactic acidosis, severe hepatomegaly with steatosis, immune reconstitution syndrome, and hepatotoxicity, particularly in those with HBV or HCV co-infections. Finally, clinical literature notes a debated but possible increased risk of cardiovascular events associated with the abacavir component.
FAQ (Frequently Asked Questions)
How Much Does Epzicom Cost Without Insurance?
Brand Epzicom costs approximately $1,800–$2,200 per 30-day supply. Generic abacavir/lamivudine is dramatically cheaper, often $50–$150/month with a coupon. Through AffordMyPrescriptions, qualifying patients receive Epzicom at no medication cost — our $69.95 monthly fee covers full advocacy and program management. Most patients find generic abacavir/lamivudine is the cheaper path.
Is Generic Lamivudine The Same As Brand Epivir?
Yes. The FDA approves generic abacavir/lamivudine as bioequivalent to brand Epzicom. Most prescribers and insurance plans prefer generic.
Why Dvo I Need HLA-B*5701 Testing Before Epzicom?
Abacavir causes severe, sometimes fatal hypersensitivity reactions in patients carrying the HLA-B*5701 allele (5–8% of the population, more common in some ethnicities). HLA-B*5701 testing is required BEFORE starting. HLA-B*5701-positive patients should NEVER receive abacavir-containing therapy (Epzicom, Triumeq, Trizivir, Ziagen).
Should I Take Epzicom Or Triumeq?
Triumeq combines dolutegravir + abacavir + lamivudine in a single tablet — a complete one-tablet regimen for HIV. Epzicom is the abacavir + lamivudine backbone alone, requiring you to add a third ARV (usually dolutegravir). For convenience and adherence, single-tablet Triumeq is often preferred. Standalone Epzicom or generic abacavir/lamivudine is useful when the third ARV needs to be different from dolutegravir (e.g., raltegravir, doravirine, certain NNRTIs) or in pediatric patients.
Can I Get Epzicom Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify. With generic abacavir/lamivudine widely available at low cost, many Medicare patients access this backbone affordably
What If I Have Hepatitis B Co-infection?
Tell your prescriber. Lamivudine has activity against HBV but lamivudine monotherapy for HBV can lead to HBV resistance. HIV/HBV co-infected patients typically need a tenofovir-containing regimen (better HBV coverage) rather than abacavir/lamivudine. Discuss with your HIV provider.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic abacavir/lamivudine (much cheaper), to single-tablet Triumeq with its own PAP, or to a tenofovir-based regimen if appropriate, state ADAP, the manufacturer’s copay program, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Epzicom, our team may be able to help you access assistance programs — or guide you to generic abacavir/lamivudine. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.